These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 8322822
1. Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation. Wilton SD, Johnsen RD, Pedretti JR, Laing NG. Am J Med Genet; 1993 Jun 15; 46(5):563-9. PubMed ID: 8322822 [Abstract] [Full Text] [Related]
2. Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family. Wilton SD, Chandler DC, Kakulas BA, Laing NG. Hum Mutat; 1994 Jun 15; 3(2):133-40. PubMed ID: 8199594 [Abstract] [Full Text] [Related]
3. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene. Habara Y, Takeshima Y, Awano H, Okizuka Y, Zhang Z, Saiki K, Yagi M, Matsuo M. J Med Genet; 2009 Aug 15; 46(8):542-7. PubMed ID: 19001018 [Abstract] [Full Text] [Related]
4. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation. Patria SY, Alimsardjono H, Nishio H, Takeshima Y, Nakamura H, Matsuo M. Proc Assoc Am Physicians; 1996 Jul 15; 108(4):308-14. PubMed ID: 8863344 [Abstract] [Full Text] [Related]
5. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. Graham IR, Hill VJ, Manoharan M, Inamati GB, Dickson G. J Gene Med; 2004 Oct 15; 6(10):1149-58. PubMed ID: 15386737 [Abstract] [Full Text] [Related]
6. DNA sequence analysis for structure/function and mutation studies in Becker muscular dystrophy. Hamed S, Sutherland-Smith A, Gorospe J, Kendrick-Jones J, Hoffman E. Clin Genet; 2005 Jul 15; 68(1):69-79. PubMed ID: 15952989 [Abstract] [Full Text] [Related]
8. Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy. Yagi M, Takeshima Y, Wada H, Nakamura H, Matsuo M. Hum Genet; 2003 Feb 15; 112(2):164-70. PubMed ID: 12522557 [Abstract] [Full Text] [Related]
10. Point mutations in the dystrophin gene: evidence for frequent use of cryptic splice sites as a result of splicing defects. Tuffery-Giraud S, Chambert S, Demaille J, Claustres M. Hum Mutat; 1999 Feb 15; 14(5):359-68. PubMed ID: 10533061 [Abstract] [Full Text] [Related]
15. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin. Le Thiet Thanh, Nguyen Thi Man, Hori S, Sewry CA, Dubowitz V, Morris GE. Am J Med Genet; 1995 Aug 28; 58(2):177-86. PubMed ID: 8533812 [Abstract] [Full Text] [Related]
16. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe. Takeshima Y, Nishio H, Sakamoto H, Nakamura H, Matsuo M. J Clin Invest; 1995 Feb 28; 95(2):515-20. PubMed ID: 7860733 [Abstract] [Full Text] [Related]
18. Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family. Ginjaar IB, Kneppers AL, v d Meulen JD, Anderson LV, Bremmer-Bout M, van Deutekom JC, Weegenaar J, den Dunnen JT, Bakker E. Eur J Hum Genet; 2000 Oct 28; 8(10):793-6. PubMed ID: 11039581 [Abstract] [Full Text] [Related]